MetLife (NYSE:MET) Price Target Raised to $110.00

Posted by George Bondi on Oct 18th, 2026

MetLife (NYSE:MET – Free Report) had its price objective upped by JPMorgan Chase & Co. from $108.00 to $110.00 in a report released on Thursday,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the financial services provider’s stock.

Other analysts have also issued research reports about the stock. Keefe, Bruyette & Woods lifted their price objective on shares of MetLife from $105.00 to $108.00 and gave the company an “outperform” rating in a research note on Tuesday, August 11th. Argus boosted their price objective on MetLife from $93.00 to $109.00 and gave the company a “buy” rating in a report on Wednesday, September 2nd. Mizuho lowered their target price on MetLife from $112.00 to $109.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 7th. Barclays upped their target price on MetLife from $97.00 to $111.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 7th. Finally, Wall Street Zen raised shares of MetLife from a “hold” rating to a “buy” rating in a research note on Sunday, September 27th. Thirteen investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $105.19.

View Our Latest Report on MetLife

MetLife Price Performance

Shares of MET opened at $100.73 on Thursday. The company has a quick ratio of 0.20, a current ratio of 0.20 and a debt-to-equity ratio of 0.52. The stock has a market cap of $64.82 billion, a PE ratio of 19.30, a PEG ratio of 0.95 and a beta of 0.78. MetLife has a 12-month low of $67.33 and a 12-month high of $102.43. The business has a 50-day simple moving average of $96.87 and a two-hundred day simple moving average of $88.73.

MetLife (NYSE:MET – Get Free Report) last posted its earnings results on Wednesday, August 5th. The financial services provider reported $2.43 earnings per share for the quarter, topping analysts’ consensus estimates of $2.30 by $0.13. MetLife had a net margin of 4.57% and a return on equity of 23.39%. The firm had revenue of $13.52 billion for the quarter, compared to analyst estimates of $19.67 billion. During the same period in the previous year, the firm posted $2.02 EPS. The company’s revenue for the quarter was up 10.5% compared to the same quarter last year. Analysts anticipate that MetLife will post 9.93 earnings per share for the current fiscal year.

MetLife Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 8th. Stockholders of record on Tuesday, November 3rd will be paid a $0.5925 dividend. The ex-dividend date is Tuesday, November 3rd. This represents a $2.37 annualized dividend and a dividend yield of 2.4%. MetLife’s dividend payout ratio is presently 45.40%.

MetLife announced that its Board of Directors has initiated a share buyback program on Wednesday, August 5th that permits the company to repurchase $3.00 billion in shares. This repurchase authorization permits the financial services provider to purchase up to 4.8% of its stock through open market purchases. Share repurchase programs are generally an indication that the company’s leadership believes its stock is undervalued.

Hedge Funds Weigh In On MetLife

Hedge funds have recently modified their holdings of the company. CX Institutional boosted its stake in MetLife by 1.3% in the third quarter. CX Institutional now owns 8,672 shares of the financial services provider’s stock valued at $817,000 after acquiring an additional 115 shares during the last quarter. McGlone Suttner Wealth Management Inc. increased its position in MetLife by 0.6% in the third quarter. McGlone Suttner Wealth Management Inc. now owns 22,391 shares of the financial services provider’s stock worth $2,108,000 after buying an additional 124 shares during the last quarter. Capital Analysts LLC increased its position in MetLife by 0.3% in the second quarter. Capital Analysts LLC now owns 38,262 shares of the financial services provider’s stock worth $3,238,000 after buying an additional 129 shares during the last quarter. Kathmere Capital Management LLC raised its stake in shares of MetLife by 2.4% in the first quarter. Kathmere Capital Management LLC now owns 5,813 shares of the financial services provider’s stock valued at $411,000 after buying an additional 136 shares during the period. Finally, Worth Asset Management LLC raised its stake in shares of MetLife by 3.1% in the second quarter. Worth Asset Management LLC now owns 4,551 shares of the financial services provider’s stock valued at $385,000 after buying an additional 138 shares during the period. Institutional investors own 94.99% of the company’s stock.

Key Headlines Impacting MetLife

Here are the key news stories impacting MetLife this week:

Positive Sentiment: JPMorgan raised its price target for MetLife from $108 to $110 and maintained an “overweight” rating. The new target implies approximately 9% upside from the referenced share price, signaling continued confidence in MetLife’s earnings outlook and valuation.
Positive Sentiment: Dowling & Partners increased its FY2026 EPS forecast to $10.30 from $10.10. The revised estimate is also above the broader consensus forecast of $9.90, suggesting expectations for stronger profitability. MetLife Hits New 52-Week High on Analyst Upgrade
Positive Sentiment: MetLife reached a new 52-week high following an analyst upgrade. The move reflects sustained investor demand and momentum around the insurer’s earnings performance and analyst outlook. MetLife Hits New 52-Week High on Analyst Upgrade
Positive Sentiment: Brokerages’ consensus price target is reported at $105.06, providing additional evidence that analysts see potential upside for MET. MetLife Consensus Price Target
Neutral Sentiment: MetLife Foundation awarded a $1 million grant to Ascendus for its Get Ready program. The initiative supports financial preparedness and may enhance MetLife’s corporate reputation, but it is unlikely to materially affect near-term earnings. Ascendus Expands Get Ready Program
Neutral Sentiment: Articles about concerts, NFL venues and events at MetLife Stadium concern the stadium’s entertainment operations, not MetLife, Inc.’s insurance and financial-services business, so they are not expected to influence MET materially.

MetLife Company Profile

(Get Free Report)

MetLife, Inc is a global financial services company that provides insurance, employee benefits and retirement solutions. Its products and services include life insurance, dental and vision coverage, disability insurance, accident and health benefits, annuities, and savings and retirement products.

The company serves individuals, employers and institutions through group benefits, workplace solutions and individual insurance offerings. MetLife also provides investment and retirement services designed to help employers and employees prepare for long-term financial needs.

Founded in 1868, MetLife is headquartered in New York City and operates through businesses in the United States and international markets, including regions across Latin America, Asia and Europe.